Search

Your search keyword '"Dye, John M."' showing total 355 results

Search Constraints

Start Over You searched for: Author "Dye, John M." Remove constraint Author: "Dye, John M." Search Limiters Full Text Remove constraint Search Limiters: Full Text
355 results on '"Dye, John M."'

Search Results

1. Anticancer pan-ErbB inhibitors reduce inflammation and tissue injury and exert broad-spectrum antiviral effects

3. Crimean-Congo hemorrhagic fever survivors elicit protective non-neutralizing antibodies that target 11 overlapping regions on glycoprotein GP38

4. SARS-COV-2 Omicron variants conformationally escape a rare quaternary antibody binding mode

5. Author Correction: Two point mutations in protocadherin-1 disrupt hantavirus recognition and afford protection against lethal infection

7. 2021 Taxonomic update of phylum Negarnaviricota (Riboviria: Orthornavirae), including the large orders Bunyavirales and Mononegavirales

8. 2020 taxonomic update for phylum Negarnaviricota (Riboviria: Orthornavirae), including the large orders Bunyavirales and Mononegavirales

9. Design and characterization of protective pan-ebolavirus and pan-filovirus bispecific antibodies

10. Development of an antibody cocktail for treatment of Sudan virus infection

11. Possibility and Challenges of Conversion of Current Virus Species Names to Linnaean Binomials.

12. Convalescent plasma anti-SARS-CoV-2 spike protein ectodomain and receptor-binding domain IgG correlate with virus neutralization

13. SARS-CoV-2 Aerosol and Intranasal Exposure Models in Ferrets

14. Characterization of the Cynomolgus Macaque Model of Marburg Virus Disease and Assessment of Timing for Therapeutic Treatment Testing

18. Protocadherin-1 is essential for cell entry by New World hantaviruses

21. Structural and mechanistic basis of neutralization by a pan-hantavirus protective antibody

22. Prophylactic Administration of the Monoclonal Antibody Adintrevimab Protects against SARS-CoV-2 in Hamster and Non-Human Primate Models of COVID-19

23. 1143. Prophylactic and Therapeutic Activity of AZD7442 (Tixagevimab/Cilgavimab) in SARS-CoV-2 Hamster Challenge Models

25. Anticancer kinase inhibitors impair intracellular viral trafficking and exert broad-spectrum antiviral effects

26. An introduction to the Marburg virus vaccine consortium, MARVAC

28. Rapid detection of an Ebola biomarker with optical microring resonators

29. Egg-Derived Anti-SARS-CoV-2 Immunoglobulin Y (IgY) With Broad Variant Activity as Intranasal Prophylaxis Against COVID-19

30. LY-CoV1404 (bebtelovimab) potently neutralizes SARS-CoV-2 variants

31. 2020 taxonomic update for phylum Negarnaviricota (Riboviria: Orthornavirae), including the large orders Bunyavirales and Mononegavirales

32. Toll-like receptor 4 mediates blood-brain barrier permeability and disease in C3H mice during Venezuelan equine encephalitis virus infection

33. Human antibody recognizing a quaternary epitope in the Puumala virus glycoprotein provides broad protection against orthohantaviruses

36. Antibody Response to SARS-CoV-2 Infection and Vaccination in COVID-19-Naïve and Experienced Individuals

38. Discovery of pan-ErbB inhibitors protecting from SARS-CoV-2 replication, inflammation, and lung injury by a drug repurposing screen

39. A Combination of Receptor-Binding Domain and N-Terminal Domain Neutralizing Antibodies Limits the Generation of SARS-CoV-2 Spike Neutralization-Escape Mutants

40. Two Distinct Lysosomal Targeting Strategies Afford Trojan Horse Antibodies With Pan-Filovirus Activity

41. On-Demand Patient-Specific Phenotype-to-Genotype Ebola Virus Characterization

43. Protective neutralizing antibodies from human survivors of Crimean-Congo hemorrhagic fever

44. Heparin: A simplistic repurposing to prevent SARS-CoV-2 transmission in light of its in-vitro nanomolar efficacy

45. 2021 Taxonomic update of phylum Negarnaviricota (Riboviria : Orthornavirae), including the large orders Bunyavirales and Mononegavirales

46. Correction to: 2021 Taxonomic update of phylum Negarnaviricota (Riboviria: Orthornavirae), including the large orders Bunyavirales and Mononegavirales

48. Prominent Neutralizing Antibody Response Targeting the Ebolavirus Glycoprotein Subunit Interface Elicited by Immunization

49. 2020 taxonomic update for phylum Negarnaviricota (Riboviria: Orthornavirae), including the large orders Bunyavirales and Mononegavirales

50. A Replication-Competent Vesicular Stomatitis Virus for Studies of SARS-CoV-2 Spike-Mediated Cell Entry and Its Inhibition

Catalog

Books, media, physical & digital resources